Cart
sales@molnova.com
OGG1-IN-O8
CAS No. 350997-39-6
OGG1-IN-O8( —— )
Catalog No. M21645 CAS No. 350997-39-6
OGG1-IN-O8 is an inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1;IC50 : 0.35 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 52 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 81 | In Stock |
|
| 25MG | 158 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 343 | In Stock |
|
| 200MG | 514 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOGG1-IN-O8
-
NoteResearch use only, not for human use.
-
Brief DescriptionOGG1-IN-O8 is an inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1;IC50 : 0.35 μM).
-
DescriptionOGG1-IN-O8 is an inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1;IC50 : 0.35 μM).
-
In VitroOGG1-IN-08 (50 μM) inhibits different DNA glycosylases activities, it inhibits?nei endonuclease VIII-like 1 DNA glycosylase (NEIL1)(84.56%), endonuclease III-like (NTH1)(63.09%), andFpg (91.74%), respectively.OGG1-IN-08 (10 μM) has a inhibitory OGG1 lyase activity on a substrate containing an AP site compared with the no inhibitor control.OGG1-IN-08 (10 μM) decreases the number of bases released into solution by OGG1 for both the 8-oxo-Gua and FapyGua compared with the no inhibitor.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor8-oxoguanine DNA glycosylase 1 (OGG1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number350997-39-6
-
Formula Weight261.12
-
Molecular FormulaC9H6Cl2N2OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (95.74 mM)
-
SMILESNNC(=O)c1sc2cccc(Cl)c2c1Cl
-
Chemical Name34-Dichloro-benzo[b]thiophene-2-carboxylic acid hydrazide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lloyd R.S. Mccullough A.K. and Donley N.?Small molecule inhibitors of 8-oxoguanine DNA glycosylase-1 (OGG1).?(2016).
molnova catalog
related products
-
Cimicifugoside
Cimicifugoside a triterpenoid isolated from Cimicifuga simplex is a novel specific nucleoside transport inhibitor. It also shows immunosuppressive activity.
-
Endothelin-2, human
Endogenous peptide found predominately in the kidney and intestine. Displays similar selectivity for ETA and ETB endothelin receptors.
-
Tremelimumab
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.
